Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Infectious disease. Approval of novel TB drug celebrated--with restraint.

Cohen J.

Science. 2013 Jan 11;339(6116):130. doi: 10.1126/science.339.6116.130. No abstract available.

PMID:
23307714
2.

Bedaquiline (Sirturo) for multidrug-resistant tuberculosis.

[No authors listed]

Med Lett Drugs Ther. 2013 Aug 19;55(1423):66-8. No abstract available.

PMID:
23959388
3.

MDR-TB has new drug foe after fast-track approval.

Voelker R.

JAMA. 2013 Feb 6;309(5):430. doi: 10.1001/jama.2013.94. No abstract available.

PMID:
23385248
4.

Microbiology. TB--a new target, a new drug.

Cole ST, Alzari PM.

Science. 2005 Jan 14;307(5707):214-5. No abstract available.

PMID:
15653490
5.

Approval of a tuberculosis drug based on a paradoxical surrogate measure.

Avorn J.

JAMA. 2013 Apr 3;309(13):1349-50. doi: 10.1001/jama.2013.623. No abstract available.

PMID:
23430122
6.

Shortening the treatment of tuberculosis.

Mitchison DA.

Nat Biotechnol. 2005 Feb;23(2):187-8. No abstract available.

PMID:
15696148
7.

Infectious disease. Drug-resistant TB on the rise.

Stokstad E.

Science. 2000 Mar 31;287(5462):2391. No abstract available.

PMID:
10766610
8.

Medicine. New TB drug promises shorter, simpler treatment.

Cohen J.

Science. 2004 Dec 10;306(5703):1872. No abstract available. Erratum in: Science. 2005 Jan 28;307(5709):519.

PMID:
15591168
9.

The "source" of drug-resistant TB outbreaks.

van Helden PD, Victor T, Warren RM.

Science. 2006 Oct 20;314(5798):419-20. No abstract available.

PMID:
17053131
10.

Bedaquiline.

Goulooze SC, Cohen AF, Rissmann R.

Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2. No abstract available.

11.

[Reasons for drug-resistant tuberculosis emergence].

Tu DH.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):403-5. Chinese. No abstract available.

PMID:
17673006
12.

Global clinical trials for the treatment of TB with thioridazine.

Boeree MJ.

Recent Pat Antiinfect Drug Discov. 2011 May;6(2):99-103. Review.

PMID:
21548879
13.

[Mycobacterium tuberculosis with extensive resistance].

Labie D.

Med Sci (Paris). 2007 Feb;23(2):205-9. Review. French. No abstract available.

14.

TB drugs chalk up rare win.

Maxmen A.

Nature. 2012 Jul 24;487(7408):413-4. doi: 10.1038/487413a. No abstract available.

PMID:
22836975
15.

Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.

Chien JY, Lai CC, Tan CK, Yu CJ, Hsueh PR.

Clin Infect Dis. 2013 Apr;56(7):1054-5. doi: 10.1093/cid/cis978. Epub 2012 Nov 21. No abstract available.

PMID:
23175554
16.

[Drug-resistance in Mycobacterium tuberculosis in Castilla y León, Spain, 2001-2005: third collaborative study].

Alberte-Castiñeiras A, Campos-Bueno A, López-Urrutia L, Alvarez-Alonso E, Megías G, Ojeda-Fernández E, López-Medrano R, Iglesias-García J, García-Carbajosa S, Pérez-Pascual P.

Enferm Infecc Microbiol Clin. 2010 Dec;28(10):706-9. doi: 10.1016/j.eimc.2010.02.011. Spanish.

PMID:
20627375
17.

Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.

Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group.

Clin Infect Dis. 2008 Mar 15;46(6):958-9. doi: 10.1086/528875. No abstract available.

PMID:
18288911
18.

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V.

Science. 2005 Jan 14;307(5707):223-7. Epub 2004 Dec 9.

19.

Infectious disease. Extensively drug-resistant TB gets foothold in South Africa.

Cohen J.

Science. 2006 Sep 15;313(5793):1554. No abstract available.

PMID:
16973846
20.

Drug-resistant Mycobacterium tuberculosis, Taiwan.

Jou R, Chuang PC, Wu YS, Yan JJ, Luh KT.

Emerg Infect Dis. 2006 May;12(5):871-2. No abstract available.

Supplemental Content

Support Center